|
Groups parameter
|
Total (n = 145)
|
With Ins
|
Without Ins
|
p value
|
|---|
|
(1)
|
(2)
|
(3)
|
|---|
|
G2 (n = 6)
|
G3 (n = 70)
|
G2 (n = 32)
|
G3 (n = 37)
|
|---|
|
Sex, n (%)
| | | | | | |
|
Male
|
117 (81)
|
6 (100)
|
57 (81)
|
27 (84)
|
27 (73)
| |
|
Female
|
28 (19)
|
0 (0)
|
13 (19)
|
5 (16)
|
10 (27)
|
0.4105
|
|
Age
| | | | | | |
|
Median (min–max) (yr)
|
74 (32–89)
|
75 (56–86)
|
73 (47–89)
|
74 (57–87)
|
76 (32–88)
|
0.5777
|
|
< 70, n (%)
|
54 (37)
|
2 (33)
|
27 (39)
|
9 (28)
|
16 (43)
| |
| ≧ 70, n (%) |
91 (63)
|
4 (67)
|
43 (61)
|
23 (72)
|
21 (57)
|
0.4230
|
|
Number of tumors, n (%)
| | | | | | |
|
Single
|
52 (36)
|
2 (33)
|
22 (31)
|
14 (44)
|
14 (38)
| |
|
Multiple
|
93 (64)
|
4 (67)
|
48 (69)
|
18 (56)
|
23 (62)
|
0.4639
|
|
Maximum diameter, n (%)
| | | | | | |
|
< 3 cm
|
116 (80)
|
5 (83)
|
54 (77)
|
27 (84)
|
30 (81)
| |
| ≧ 3 cm |
29 (20)
|
1 (17)
|
16 (23)
|
5 (16)
|
7 (19)
|
0.7623
|
|
History of recurrence, n (%)
| | | | | | |
|
Primary
|
103 (71)
|
3 (50)
|
54 (77)
|
17 (53)
|
29 (78)
| |
|
Recurrent
|
42 (29)
|
3 (50)
|
16 (23)
|
15 (47)
|
8 (22)
|
0.0492
|
|
Concomitant CIS, n (%)
| | | | | | |
|
No
|
111 (77)
|
5 (83)
|
43 (61)
|
31 (97)
|
32 (86)
| |
|
Yes
|
34 (23)
|
1 (17)
|
27 (39)
|
1 (3)
|
5 (14)
|
0.0001
|
|
WHO grade 1973, n (%)
| | | | | | |
|
G2
|
38 (26)
|
6 (100)
|
0 (0)
|
32 (100)
|
0 (0)
| |
|
G3
|
107 (74)
|
0 (0)
|
70 (100)
|
0 (0)
|
37 (100)
|
< 0.0001
|
|
Second TURBT, n (%)
| | | | | | |
|
No
|
46 (32)
|
2 (33)
|
10 (14)
|
24 (75)
|
10 (27)
| |
|
Yes
|
99 (68)
|
4 (67)
|
60 (86)
|
8 (25)
|
27 (73)
|
< 0.0001
|
|
Ins in a series, n (%)
| | | | | | |
|
No
|
69 (48)
|
0 (0)
|
0 (0)
|
32 (100)
|
37 (100)
| |
|
Yes
|
76 (52)
|
6 (100)
|
70 (100)
|
0 (0)
|
0 (0)
|
< 0.0001
|
|
Ins in whole lifetime, n (%)
| | | | | | |
|
No
|
60 (41)
|
0 (0)
|
0 (0)
|
29 (91)
|
31 (84)
| |
|
Yes
|
85 (59)
|
6 (100)
|
70 (100)
|
3 (9)
|
6 (16)
|
< 0.0001
|
- HG high grade, Ins intravesical instillation therapy, G2 grade 2, G3 grade 3, CIS carcinoma in situ, TURBT transurethral resection of bladder tumor
